Skip to content

Peripartum Mental Health Cohort Study in Guangzhou

Peripartum Mental Health Cohort Study in Guangzhou

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04499066
Enrollment
3000
Registered
2020-08-05
Start date
2012-02-01
Completion date
2038-12-31
Last updated
2023-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression

Keywords

Peripartum, Mental health, Risk factors, Pregnancy outcome, Cohort

Brief summary

The purpose of this study is to determine the incidence,development trajectory and risk factors of the main peripartum mental health problems as well as explore its adverse outcomes.

Detailed description

Peripartum mental health problems (such as anxiety and depression), affecting more than 20% of mothers, is one of the most common complications around childbirth and gradually have become global public health issues. However, little is known about the course of peripartum mental health problems and possible fluctuations, as well as related risk factors among Chinese women. In addition, there are no effective prediction and preventive strategies for postpartum depression. The Peripartum Mental Health Cohort Study in Guangzhou will collect the epidemiological, clinical information and biological specimens across pregnancy and childbirth to establish trajectory of peripartum mental health and identify the factors influencing the fluctuations and build a comprehensive prediction model of postpartum depression, as well as explore its adverse outcomes. This study would help to determine the timing of screening and target interventions to improve women's and their offspring's health.

Interventions

None listed

Sponsors

Guangzhou Women and Children's Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

1. Pregnant women with \<20 weeks of gestation 2. Pregnant women intended to eventually deliver in Guangzhou Women and Children's Medical Center 3. Permanent residents or families intended to remain in Guangzhou with their child for more than 3 years

Exclusion criteria

1. Combined with heart disease, hypertension, diabetes or hyperthyroidism 2. Taking anti-depressants and other treatments for depression 3. Participants was in infection status when the biological samples were collected

Design outcomes

Primary

MeasureTime frameDescription
Change of prevalence of maternal prenatal depressionbefore 20th gestational week, after 33th gestational week and prior to deliveryUsing Self-rating Depression Scale (SDS) to assess maternal depressive symptoms during pregnancy. SDS scores ≥53 is defined as prenatal depressive symptoms.
Change of prevalence of maternal postpartum depression in the first year after delivery6 weeks, 6 months and 1 year after deliveryUsing Edinburgh Postnatal Depression Scale (EPDS) to assess postpartum depressive symptoms. EPDS scores ≥13 is defined as postpartum depressive symptoms.

Secondary

MeasureTime frameDescription
Levels of maternal inflammatory factors during pregnancyDuring period of 2-3 trimesters of pregnancyUsing women's blood samples to test the concentration of inflammatory factors, including CRP, IL-6, TNF-α, etc.
Change of prevalence of maternal anxiety during pregnancybefore 20th gestational week, after 33th gestational week and prior to deliveryUsing Self-rating Anxiety Scale (SAS) to assess maternal anxiety during pregnancy. SAS scores ≥50 is defined as anxiety.
Child's neurodevelopment at early childhoodAt child's age of 1 yearAssessed by using the Gesell Developmental Schedules, which includes adaptive, gross motor, fine motor, language, and social function domains. Higher score in each domain is considered a better outcome, while no more than 85 is defined as suspected development delay.
Prevalence of preterm birth, small for gestational age, low birth weightAt deliveryObtained from electronic medical records.
Level of maternal cortisol during pregnancyDuring period of 2-3 trimesters of pregnancyUsing women's blood samples to test the concentration of cortisol.

Countries

China

Contacts

Primary ContactXiu Qiu, PhD
qxiu0161@163.com0086 20 38367160
Backup ContactDongmei Wei, MSc
0086 20 38367159

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026